 |
Ben Butkus is senior editor of GenomeWeb's premium content and the editor of PCR Insider. He covers technologies and trends in PCR, qPCR, nucleic acid amplification, and sample prep. E-mail Ben Butkus or follow his GenomeWeb Twitter account at @PCRInsider. |
Australia's SpeeDx Demonstrates Multiplexed MNAzyme qPCR; Looks to Move Tech to MDx Market
December 20, 2012
Australia's SpeeDx Demonstrates Multiplexed MNAzyme qPCR; Looks to Move Tech to MDx Market
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Nascent Australian Firm SpeeDx Seeks Licensees, Partners for 'MNAzyme' Tech
April 1, 2010 / PCR Insider - UW Researchers Commercializing Nanotip Device for DNA Isolation; Exploring Tech for POC Dx
May 16, 2013 / PCR Insider - China's Zeesan Biotech Developing Portfolio of Melt Curve MDx Assays after SFDA Approves TB Tests
April 25, 2013 / PCR Insider - IP Watch: BioFire Diagnostics, SpeeDx, IntegenX, Life Technologies, Stanford Among US Patent Winners
March 14, 2013 / PCR Insider - Alere Garners Up to $42.2M in Grants and Loans from Gates Foundation for POC MDx Platforms
March 1, 2013 / GenomeWeb Daily News